Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Boyer

Showing results (351-360 of 390) with videos related to

Pageof 39
Sort By:
Oncogene|January 1, 1999
Molecular and immunological analysis of genetic prostate specific antigen (PSA) vaccineJ J Kim, N N Trivedi, D M Wilson, et al.
European Journal of Immunology|April 29, 1998
Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogensJ J Kim, N N Trivedi, L K Nottingham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2017
Clinical and Immunologic Biomarkers for Histologic Regression of High-Grade Cervical Dysplasia and Clearance of HPV16 and HPV18 after ImmunotherapyMatthew P Morrow, Kimberly A Kraynyak, Albert J Sylvester, et al.
Vaccine|November 18, 2005
A dose sparing effect by plasmid encoded IL-12 adjuvant on a SIVgag-plasmid DNA vaccine in rhesus macaquesEva B Schadeck, Maninder Sidhu, Michael A Egan, et al.
Vaccine|March 6, 2007
Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaquesSiew-Yen Chong, Michael A Egan, Michele A Kutzler, et al.
Journal for Immunotherapy of Cancer|July 7, 2021
Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumorsRobert H Vonderheide, Kimberly A Kraynyak, Anthony F Shields, et al.
AIDS Research and Human Retroviruses|August 3, 2005
Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virusMichael A Egan, Siew Yen Chong, Shakuntala Megati, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2007
Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmidJean D Boyer, Tara M Robinson, Michele A Kutzler, et al.
Vaccine|February 1, 2024
Strong immunogenicity & protection in mice with PlaCCine: A COVID-19 DNA vaccine formulated with a functional polymerSubeena Sood, Majed M Matar, Jessica Kim, et al.
Physical Review Letters|September 26, 2012
Final analysis and results of the Phase II SIMPLE dark matter searchM Felizardo, T A Girard, T Morlat, et al.
Pageof 39

Showing results (351-360 of 390) with videos related to

Sort By:
Pageof 39
Oncogene|January 1, 1999
Molecular and immunological analysis of genetic prostate specific antigen (PSA) vaccineJ J Kim, N N Trivedi, D M Wilson, et al.
European Journal of Immunology|April 29, 1998
Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogensJ J Kim, N N Trivedi, L K Nottingham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2017
Clinical and Immunologic Biomarkers for Histologic Regression of High-Grade Cervical Dysplasia and Clearance of HPV16 and HPV18 after ImmunotherapyMatthew P Morrow, Kimberly A Kraynyak, Albert J Sylvester, et al.
Vaccine|November 18, 2005
A dose sparing effect by plasmid encoded IL-12 adjuvant on a SIVgag-plasmid DNA vaccine in rhesus macaquesEva B Schadeck, Maninder Sidhu, Michael A Egan, et al.
Vaccine|March 6, 2007
Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaquesSiew-Yen Chong, Michael A Egan, Michele A Kutzler, et al.
Journal for Immunotherapy of Cancer|July 7, 2021
Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumorsRobert H Vonderheide, Kimberly A Kraynyak, Anthony F Shields, et al.
AIDS Research and Human Retroviruses|August 3, 2005
Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virusMichael A Egan, Siew Yen Chong, Shakuntala Megati, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2007
Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmidJean D Boyer, Tara M Robinson, Michele A Kutzler, et al.
Vaccine|February 1, 2024
Strong immunogenicity & protection in mice with PlaCCine: A COVID-19 DNA vaccine formulated with a functional polymerSubeena Sood, Majed M Matar, Jessica Kim, et al.
Physical Review Letters|September 26, 2012
Final analysis and results of the Phase II SIMPLE dark matter searchM Felizardo, T A Girard, T Morlat, et al.
Pageof 39